» Articles » PMID: 2041715

Inositol Trisphosphate Enhances Ca2+ Oscillations but Not Ca(2+)-induced Ca2+ Release from Cardiac Sarcoplasmic Reticulum

Overview
Journal Pflugers Arch
Specialty Physiology
Date 1991 Mar 1
PMID 2041715
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The role of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] in excitation-contraction coupling in cardiac muscle is still unclear, although many laboratories are beginning to assume a critical role for this putative second messenger. Earlier studies from this laboratory [Nosek et al. (1986) Am J Physiol 250:C807] found that Ins(1,4,5)P3 enhanced spontaneous Ca2+ release and the caffeine sensitivity of Ca2+ release from myocardial sarcoplasmic reticulum (SR) and proposed an increase in the Ca2+ sensitivity of the release as a possible mechanism. In order to clarify the physiological relevance of these actions of Ins(1,4,5)P3 and specifically to test the effect of Ins(1,4,5)P3 on the Ca2+ sensitivity of Ca2+ release, we compared the effects of Ins(1,4,5)P3 on Ca2+ oscillations and on Ca(2+)-induced Ca2+ release (CICR) from the SR in saponin-skinned rat papillary muscle. We found that: (a) 30 microM Ins(1,4,5)P3 enhanced the Ca2+ oscillations (measured by tension oscillations) from the rat cardiac SR, consistent with the previous report on guinea pig tissue; (b) both GTP and GTP[S] enhanced Ca2+ oscillations. The effect was not additive to that of Ins(1,4,5)P3 indicating that two different Ca(2+)-release pools do not exist in cardiac SR; (c) 30 microM Ins(1,4,5)P3 had no effect on the Ca2+ sensitivity of CICR; (d) Ins(1,4,5)P3 (up to 30 microM) had no effect on SR Ca2+ loading. The studies were performed in the presence of Cd2+ or 2,3-bisphosphoglycerate, agents that inhibit Ins(1,4,5)P3 hydrolysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Activation of IPR in atrial cardiomyocytes leads to generation of cytosolic cAMP.

Akerman E, Read M, Bose S, Koschinski A, Capel R, Chao Y Am J Physiol Heart Circ Physiol. 2024; 327(4):H830-H846.

PMID: 39093001 PMC: 11482242. DOI: 10.1152/ajpheart.00152.2024.


Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.

Kockskamper J, Zima A, Roderick H, Pieske B, Blatter L, Bootman M J Mol Cell Cardiol. 2008; 45(2):128-47.

PMID: 18603259 PMC: 2654363. DOI: 10.1016/j.yjmcc.2008.05.014.


Calcium and arrhythmogenesis.

Ter Keurs H, Boyden P Physiol Rev. 2007; 87(2):457-506.

PMID: 17429038 PMC: 4332537. DOI: 10.1152/physrev.00011.2006.


Analysis of inositol phosphates in heart tissue using anion-exchange high-performance liquid chromatography.

Woodcock E Mol Cell Biochem. 1997; 172(1-2):121-7.

PMID: 9278239


Inositol-1,4,5-trisphosphate mass content in isolated perfused rat heart during alpha-1-adrenoceptor stimulation.

Hanem S, Enger M, Skomedal T, Osnes J Mol Cell Biochem. 1996; 163-164:167-72.

PMID: 8974053 DOI: 10.1007/BF00408654.


References
1.
Heathers G, Evers A, Corr P . Enhanced inositol trisphosphate response to alpha 1-adrenergic stimulation in cardiac myocytes exposed to hypoxia. J Clin Invest. 1989; 83(4):1409-13. PMC: 303836. DOI: 10.1172/JCI114030. View

2.
Saida K, Twort C, van Breemen C . The specific GTP requirement for inositol 1,4,5-trisphosphate-induced Ca2+ release from skinned vascular smooth muscle. J Cardiovasc Pharmacol. 1988; 12 Suppl 5:S47-50. View

3.
Prasad M, Engelman R, Otani H, Cordis G, Das D . Enhanced phosphodiesteratic breakdown and turnover of phosphoinositides during reperfusion of ischemic rat heart. Circ Res. 1988; 63(5):930-6. DOI: 10.1161/01.res.63.5.930. View

4.
Vergara J, Tsien R, Delay M . Inositol 1,4,5-trisphosphate: a possible chemical link in excitation-contraction coupling in muscle. Proc Natl Acad Sci U S A. 1985; 82(18):6352-6. PMC: 391052. DOI: 10.1073/pnas.82.18.6352. View

5.
Mignery G, Sudhof T, Takei K, De Camilli P . Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor. Nature. 1989; 342(6246):192-5. DOI: 10.1038/342192a0. View